AstraZeneca

A blood cancer diagnosis can change everything. For Erica, a diagnosis of lymphoma came during what should have been one of the happiest times of her life. With support from family, friends and care teams she navigated treatment and uncertainty with resilience. This Blood Cancer Awareness Month, we are sharing stories that highlight the realities of blood cancer and the need for continued progress in care. Discover Erica’s story. #BloodCancerAwarenessMonth

How do you make a packaging standard that has supported patients for over 50 years more sustainable? We’re establishing mono-polypropylene (PP) as an alternative to traditional PVC-Aluminium blister packs, which are challenging to recycle in traditional waste streams. Our life cycle approach to more circular packaging solutions brings together scientific rigour, patient-centred design and collaboration cross-sector collaboration through the Pharmaceutical Manufacturing Forum. At Climate Week NYC next week, we’ll be engaging across our sector and beyond to keep raising the bar and finding new ways to build a healthier future, for people, society and the planet. Find out more: https://lnkd.in/eQ55i83n #WhatScienceCanDo #ClimateWeekNYC #PackagingInnovation

Lead the way in sustainability with us. Join us in helping to reduce environmental impact and support ambitious sustainability goals. From lowering our operational carbon footprint and reducing waste, to improving energy and water efficiency, we’re working to make a meaningful difference - always with ethics, integrity, and transparency at the heart of what we do. Join us in creating everyday impact through sustainability. Visit: https://lnkd.in/eDHhYCh4 #AstraZeneca

Our progress in embedding sustainability across our global manufacturing footprint and supply network has been recognised by the Gartner Supply Chain Top 25 five years in a row. From adopting lower environmental impact technologies at our sites, to supplier partnerships across our value chain, we’re taking action to reduce emissions in our medicine manufacturing and supply chains, while continuing to reach patients around the world. Our sustainability focus helps us build a more resilient supply network, supporting our ambition to build a healthier future.

En tant que l’une des figures de proue du secteur pharmaceutique au Canada, AstraZeneca est fière d’accroître sa présence dans l’écosystème florissant des sciences de la vie en Ontario. Notre investissement de 820 millions $ CA en Ontario permettra la création de plus de 700 emplois et aidera à faire avancer la science afin d’offrir des médicaments novateurs pour diverses maladies, telles que le cancer de la prostate, du poumon et du sein, l’insuffisance rénale aiguë, la MPOC, l’amyloïdose et l’hypophosphatasie.   Nous remercions le Ontario Government | Gouvernement de l’Ontario de toujours être prêt à travailler avec nous au renforcement de la position de l’Ontario en tant que centre mondial des sciences de la vie et de l’innovation.

Our scientists in Oncology R&D are exploring a range of translational approaches to help extend the potential benefits of immunotherapy to more patients. From models that may better reflect human biology, to digital twins that help simulate treatment response, we’re aiming to advance a suite of translational approaches that could provide deeper mechanistic insights and help shape future combination strategies. Discover more in our latest article: https://lnkd.in/eT6qVxbJ #WhatScienceCanDo

As one of Canada’s leading pharmaceutical companies, we are proud to continue growing our presence in Ontario’s thriving life sciences ecosystem. Our C$820 million investment in Ontario is supporting the creation of 700+ jobs and help advance innovative medicines for such disease areas as Prostate, Lung and Breast Cancers, Acute Kidney Failure, COPD, Amyloidosis, and Hypophosphatasia.   Thank you to the Ontario Government | Gouvernement de l’Ontario for its ongoing support and partnership as we work together to strengthen Ontario’s position as a global hub for life sciences and innovation.

When a chest X-ray unexpectedly revealed a tumour in her left lung, Jan quickly learned how biomarker testing, such as testing for EGFR mutations, could help determine the best possible treatment for her specific cancer type. Lung cancer remains the leading cause of cancer death globally. At this year’s World Conference on Lung Cancer, stories like Jan’s serve as a clear reminder that early detection, biomarker testing at diagnosis and precision medicine can contribute to improved outcomes and longer-term survival. By identifying the specific genetic characteristics of a tumour early, clinical teams can match patients to targeted treatment strategies when it matters most. #WCLC26

Addressing inequity in lung health starts with understanding where care gaps exist and who is most impacted. A new Lung Health Equity Framework provides a consistent way to identify and measure this across COPD and lung cancer care pathways. Developed with input from an international advisory committee and policy experts from The London School of Economics and Political Science (LSE), this evidence-based resource can help inform targeted action – giving policy makers, health system leaders and advocates: · A shared set of equity indicators to pinpoint care gaps across COPD and lung cancer pathways · A way to identify underserved populations most impacted · A decision-making tool to direct resources where they can have the greatest impact Swipe through to see the key Framework policy recommendations for advancing lung health equity. #LungHealthEquity #LungHealth #HealthEquity The Lung Health Equity Framework has been developed by LCP Health and initiated and funded by AstraZeneca.

TIME has ranked us #5 out of 1,000 companies on the 2026 World’s Best Companies list, and #1 in our industry. Recognised for the fourth year in a row, we increased our scores across employee satisfaction, revenue growth and sustainability transparency. Thank you to our colleagues and partners, whose commitment and collaboration have made this possible. https://lnkd.in/evwqdFYq #WhatScienceCanDo #TIME #WorldsBestCompanies